Zinc Ion-crosslinked Polycarbonate/heparin Composite Coatings for Biodegradable Zn-alloy Stent Applications
Overview
Affiliations
Zinc and its alloys are the best candidates for biodegradable cardiovascular stents due to their good corrosion rate and biocompatibility in vasculature. However, the cytotoxicity caused by the rapid release of zinc ions during the initial degradation stage and the lack of an anticoagulant function are huge challenges for their practical clinical applications. In this work, we developed a zinc ion-crosslinked polycarbonate/heparin composite coating via electrophoretic deposition (EPD) to improve the biocompatibility and provide anticoagulant functions for Zn-alloy stents. Both electrochemical tests and in vitro immersion tests demonstrated an enhanced corrosion resistance and lower Zn ion release rate of the coated Zn alloys. Enhanced adhesion and proliferation of endothelial cells on coated Zn alloys were also observed, indicating faster reendothelialization than that on bare Zn alloys. Moreover, the surface erosion of the composite coating led to the uniform and long-term release of heparin, which remarkably inhibited the adhesion and activation of platelets, and may have endowed the coated Zn-alloy stents with long-term anticoagulant functions.
Influence of casein on the degradation process of polylactide-casein coatings for resorbable alloys.
Cesarz-Andraczke K, Staszuk M, Tuncay T, Wozniak A, Smok W, Tuncay B Sci Rep. 2024; 14(1):18946.
PMID: 39147799 PMC: 11327277. DOI: 10.1038/s41598-024-69956-6.
Zhang W, Dai M, Zhu Y, Li S, Sun Y, Liu X Bioact Mater. 2024; 37:549-562.
PMID: 38756420 PMC: 11096721. DOI: 10.1016/j.bioactmat.2024.03.037.
Lee H, Won D, Park S, Park Y, Kim J, Han G Bioact Mater. 2024; 37:172-190.
PMID: 38549771 PMC: 10972844. DOI: 10.1016/j.bioactmat.2024.03.018.
Polymer-Drug Anti-Thrombogenic and Hemocompatible Coatings as Surface Modifications.
Zawidlak-Wegrzynska B, Rydz J, Musiol M, Radziwon-Balicka A Pharmaceutics. 2024; 16(3).
PMID: 38543326 PMC: 10974185. DOI: 10.3390/pharmaceutics16030432.
Yuan K, Deng C, Tan L, Wang X, Yan W, Dai X Bioact Mater. 2024; 35:306-329.
PMID: 38362138 PMC: 10867564. DOI: 10.1016/j.bioactmat.2024.01.017.